This compound is a pharmaceutical intermediate specifically used in the manufacturing process of rosuvastatin, a lipid-lowering medication. It serves as a key building block in the synthesis of this statin drug.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 147118-37-4
N-[4-(4-Fluorophenyl)-5-formyl-6-(1-methylethyl)-2-pyrimidinyl]-N-methylmethanesulfonamide
active pharmaceutical ingredient
N-[4-(4-fluorophenyl)-5-[(E)-3-oxoprop-1-enyl]-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamide
n.a
Methyl 5-chloropyrazine-2-carboxylate
Pharmaceutical intermediate for rosuvastatin
1,1-Dimethylethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoate
Pharmaceutical intermediate for rosuvastatin
1,1,2-TRIMETHYL-1H-BENZO[E]INDOLE
Pharmaceutical intermediate for rosuvastatin
Rosuvastatin ethyl ester
Pharmaceutical intermediate for rosuvastatin
(R,E)-Methyl 3-((tert-butyldimethylsilyl)oxy)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-5-oxohept-6-enoate
Pharmaceutical intermediate
(R,E)-Methyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate
Pharmaceutical intermediate for statin synthesis
N-[4-(4-fluorophenyl)-5-formyl-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamide
WOCOTUDOVSLFOB-UHFFFAOYSA-N
CC(C)C1=NC(=NC(=C1C=O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C